NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Chase

(CCF) - Get Report

downgraded to hold at TheStreet Ratings.

Chesapeake Energy

(CHK) - Get Report

downgraded at Bernstein from Outperform to Market Perform, Bernstein Research said. $21 price target. Company lacks near-term catalysts.

Majesco Entertainment

(COOL)

downgraded to hold at TheStreet Ratings.

E*Trade

(ETFC) - Get Report

upgraded at BGB from Sell to Hold, BGB Securities said. Valuation call, based on a $7.50 price target.

Fortinet

(FTNT) - Get Report

upgraded at UBS to Buy from Neutral, UBS said. $28 price target. Upside to street estimates on increasing market share.

Genon Energy

(GEN) - Get Report

upgraded at UBS to Neutral from Sell, UBS said. $1.50 price target. Shares fairly valued.

Hill-Rom

(HRC) - Get Report

upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $34 price target.

Johnson & Johnson

(JNJ) - Get Report

upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $74 price target.

McDonald's

(MCD) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $92 price target. Company faces multiple growth headwinds.

Navistar

(NAV) - Get Report

upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Risk/reward is more balanced at current levels.

Petrologistics

(PDH)

rated new Buy at UBS. $16.50 price target. Propylene price dip and stock weakness gives a good buying opportunity.

PetSmart

(PETM)

rated new Overweight at Morgan Stanley. $75 price target. Company can deliver stable growth and gain market share.

Power Integrations

(POWI) - Get Report

downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Company will likely face weaker customer demand. $43 price target.

UnitedHealth

(UNH) - Get Report

rated new Overweight at JP Morgan. $72 price target. Company remains a core holding, despite industry regulatory risks.

Woodward

(WWD) - Get Report

rated new Buy at Keybanc. $45 price target. Company is leveraged to late-cycle secular growth.

STOCK COMMENTS / EPS CHANGES

Biogen Idec

(BIIB) - Get Report

target raised at Oppenheimer to $145. Analyst day highlights pipeline strength. Outperform rating.

CNO Financial

(CNO) - Get Report

added to Conviction Buy List at Goldman. Company can grow faster than its life insurance peers. Buy rating and $9 price target.

Forest Laboratories

(FRX)

estimates cut at Morgan Stanley through 2014, Morgan Stanley said. Company lowered its guidance. $35 price target.

Great Plains Energy

(GXP)

added to Top Picks Live! at Citigroup. $23 price target. Valuation gap should narrow as rates come closer to fruition and regulatory concerns diminish.

Hershey

(HSY) - Get Report

added to Conviction Buy List at Goldman. Company can deliver above-average sales and earnings growth. $76 price target.

JPMorgan Chase

(JPM) - Get Report

target lowered at Oppenheimer to $56. Contraction of market multiple. Outperform rating.

Mastercard

(MA) - Get Report

numbers lowered at Jefferies. Shares of MA now seen reaching $507, Jefferies said. Estimates also lowered on FX and macro risks. Buy rating.

Altria

(MO) - Get Report

target raised at Morgan Stanley to $30, according to Morgan Stanley. There's room for industry price increases in the U.S.

Scotts Miracle-Gro

(SMG) - Get Report

numbers cut at BofA/Merrill. Shares of SMG now seen reaching $39, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Underperform rating.

AT&T

(T) - Get Report

target raised at Jefferies to $36, Jefferies said. Divestiture of Advertising Solutions should help value gap close. Hold rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Is Facebook Lying About 900 Million Users?

>>Sirius' Greatest Fear - Apple in Driver's Seat

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.